GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » Asset Turnover

Shanghai HeartCare Medical Technology (HKSE:06609) Asset Turnover : 0.10 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Shanghai HeartCare Medical Technology's Revenue for the six months ended in Dec. 2023 was HK$134.3 Mil. Shanghai HeartCare Medical Technology's Total Assets for the quarter that ended in Dec. 2023 was HK$1,340.3 Mil. Therefore, Shanghai HeartCare Medical Technology's Asset Turnover for the quarter that ended in Dec. 2023 was 0.10.

Asset Turnover is linked to ROE % through Du Pont Formula. Shanghai HeartCare Medical Technology's annualized ROE % for the quarter that ended in Dec. 2023 was -7.24%. It is also linked to ROA % through Du Pont Formula. Shanghai HeartCare Medical Technology's annualized ROA % for the quarter that ended in Dec. 2023 was -6.48%.


Shanghai HeartCare Medical Technology Asset Turnover Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology Asset Turnover Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
- 0.03 0.08 0.12 0.18

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only 0.05 0.05 0.08 0.09 0.10

Competitive Comparison of Shanghai HeartCare Medical Technology's Asset Turnover

For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai HeartCare Medical Technology's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Shanghai HeartCare Medical Technology's Asset Turnover falls into.



Shanghai HeartCare Medical Technology Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Shanghai HeartCare Medical Technology's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=254.133/( (1465.754+1313.896)/ 2 )
=254.133/1389.825
=0.18

Shanghai HeartCare Medical Technology's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=134.27/( (1366.783+1313.896)/ 2 )
=134.27/1340.3395
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Shanghai HeartCare Medical Technology  (HKSE:06609) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Shanghai HeartCare Medical Technology's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-86.79/1199.422
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-86.79 / 268.54)*(268.54 / 1340.3395)*(1340.3395/ 1199.422)
=Net Margin %*Asset Turnover*Equity Multiplier
=-32.32 %*0.2004*1.1175
=ROA %*Equity Multiplier
=-6.48 %*1.1175
=-7.24 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Shanghai HeartCare Medical Technology's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-86.79/1340.3395
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-86.79 / 268.54)*(268.54 / 1340.3395)
=Net Margin %*Asset Turnover
=-32.32 %*0.2004
=-6.48 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Shanghai HeartCare Medical Technology Asset Turnover Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Traded in Other Exchanges
N/A
Address
No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.
Executives
Ding Kui 2201 Interest of corporation controlled by you
Wisary Limited 2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines